Livingstone SJ, Looker HC, Hothersall EJ, Wild SH, Lindsay RS, Chalmers J, et al. Risk of cardiovascular disease and total mortality in adults with type 1 diabetes: Scottish registry linkage study. PLoS Med. 2012;9:e1001321. https://doi.org/10.1371/journal.pmed.1001321.

Article  PubMed  PubMed Central  Google Scholar 

Lind M, Svensson A-M, Kosiborod M, Gudbjörnsdottir S, Pivodic A, Wedel H, et al. Glycemic control and excess mortality in type 1 diabetes. N Engl J Med. 2014;371:1972–82. https://doi.org/10.1056/NEJMoa1408214.

Article  CAS  PubMed  Google Scholar 

Kalyani RR, Everett BM, Perreault L, Michos ED. Heart Disease and Diabetes. In: Lawrence JM, Casagrande SS, Herman WH, Wexler DJ, Cefalu WT, editors. Diabetes in America [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); 2023 [cited 2024 Jan 26]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK597416/.

Popovic DS, Koufakis T, Papanas N. The recent trends in all-cause and cardiovascular mortality amongpeople with type 1 diabetes mellitus - success is still far away, and we must do better! CVP [Internet]. 2023 [cited 2024 Feb 6];21:219–21. https://doi.org/10.2174/1570161121666230817105105

Rawshani A, Rawshani A, Franzén S, Eliasson B, Svensson A-M, Miftaraj M, et al. Mortality and cardiovascular disease in type 1 and type 2 diabetes. N Engl J Med. 2017;376:1407–18. https://doi.org/10.1056/NEJMoa1608664.

Article  PubMed  Google Scholar 

Svane J, Lynge TH, Pedersen-Bjergaard U, Jespersen T, Gislason GH, Risgaard B, et al. Cause-specific mortality in children and young adults with diabetes mellitus: a Danish nationwide cohort study. Eur J Prev Cardiol [Internet]. 2021 [cited 2024 Feb 6];28:159–65. https://doi.org/10.1177/2047487319836550

Seo DH, Kim M, Suh YJ, Cho Y, Ahn SH, Hong S, et al. Association between age at diagnosis of type 2 diabetes and cardiovascular morbidity and mortality risks: a nationwide population-based study. Diabetes Res Clin Pract. 2024;208:111098.

Article  CAS  PubMed  Google Scholar 

Shah AS, Maahs DM, Stafford JM, Dolan LM, Lang W, Imperatore G, et al. Predictors of dyslipidemia over time in youth with type 1 diabetes: for the search for diabetes in youth study. Diabetes Care. 2017;40:607–13. https://doi.org/10.2337/dc16-2193.

Article  PubMed  PubMed Central  Google Scholar 

Dabelea D, Stafford JM, Mayer-Davis EJ, D’Agostino R, Dolan L, Imperatore G, et al. Association of type 1 diabetes vs type 2 diabetes diagnosed during childhood and adolescence with complications during teenage years and young adulthood. JAMA. 2017;317:825–35. https://doi.org/10.1001/jama.2017.0686.

Article  PubMed  PubMed Central  Google Scholar 

Kahkoska AR, Shay CM, Crandell J, Dabelea D, Imperatore G, Lawrence JM, et al. Association of race and ethnicity with glycemic control and hemoglobin A1c Levels in youth with type 1 diabetes. JAMA Netw Open. 2018;1:e181851. https://doi.org/10.1001/jamanetworkopen.2018.1851.

Article  PubMed  PubMed Central  Google Scholar 

Tremblay ES, Liu E, Laffel LM. Health disparities likely emerge early in the course of type-1 diabetes in youth. J Diabetes Sci Technol. 2022;16:929–33. https://doi.org/10.1177/19322968221082646.

Article  PubMed  PubMed Central  Google Scholar 

Secrest AM, Becker DJ, Kelsey SF, Laporte RE, Orchard TJ. Cause-specific mortality trends in a large population-based cohort with long-standing childhood-onset type 1 diabetes. Diab [Internet]. 2010;59:3216–22. Available from: PM:20739685

Roy M, Rendas-Baum R, Skurnick J. Mortality in African-Americans with type 1 diabetes: the New Jersey 725. Diabet Med. 2006;23:698–706.

Article  CAS  PubMed  Google Scholar 

Borrell LN, Elhawary JR, Fuentes-Afflick E, Witonsky J, Bhakta N, Wu AHB, et al. Race and genetic ancestry in medicine — a time for reckoning with racism. Malina D, editor. N Engl J Med [Internet]. 2021 [cited 2024 Feb 6]; 384:474–80. https://doi.org/10.1111/j.1464-5491.2006.01901.x

Andreae MH, White RS. Black race is a social construct, and there is no biological mechanism to justify differences in antiemetic prophylaxis. Anesth Analg. 2023;137:e54–5. https://doi.org/10.1213/ANE.0000000000006725.

Article  PubMed  Google Scholar 

Mayer-Davis EJ, Dabelea D, Lawrence JM. Incidence trends of type 1 and type 2 diabetes among youths, 2002–2012. N Engl J Med. 2017;377:301. https://doi.org/10.1056/NEJMc1706291.

Article  PubMed  PubMed Central  Google Scholar 

Wagenknecht LE, Lawrence JM, Isom S, Jensen ET, Dabelea D, Liese AD, et al. Trends in incidence of youth-onset type 1 and type 2 diabetes in the USA, 2002–18: results from the population-based search for diabetes in youth study. Lancet Diabetes Endocrinol [Internet]. 2023;11:242–50. https://doi.org/10.1016/S2213-8587(23)00025-6.

Article  PubMed  Google Scholar 

Burkart K, Causey K, Cohen AJ, Wozniak SS, Salvi DD, Abbafati C, et al. Estimates, trends, and drivers of the global burden of type 2 diabetes attributable to PM2·5 air pollution, 1990–2019: an analysis of data from the global burden of disease study 2019. Lancet Planet Health [Internet]. 2022;6:e586-600. https://doi.org/10.1056/NEJMe1616575.

Article  Google Scholar 

Ingelfinger JR, Jarcho JA. Increase in the Incidence of Diabetes and Its Implications. N Engl J Med [Internet]. 2017;376:1473–4. https://doi.org/10.1056/NEJMe1616575.

Article  PubMed  Google Scholar 

Perng W, Conway R, Mayer-Davis E, Dabelea D. Youth-onset type 2 diabetes: the epidemiology of an awakening epidemic. Diabetes Care. 2023;46:490–9. https://doi.org/10.2337/dci22-0046.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Centers for disease control. National diabetes statistics report: estimates of diabetes and its burden in the United States [Internet]. 2023 Nov. Available from: https://www.cdc.gov/diabetes/data/statistics-report/index.html#print

Parker ED, Lin J, Mahoney T, Ume N, Yang G, Gabbay RA, et al. Economic costs of diabetes in the U.S. in 2022. Diabetes care [Internet]. 2024 [cited 2024 Feb 3];47:26–43. https://doi.org/10.2337/dci23-0085

Collins R, Armitage J, Parish S, Sleigh P, Peto R, Heart Protection Study Collaborative Group. MRC/BHF Heart protection study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet. 2003;361:2005–16. https://doi.org/10.1016/s0140-6736(03)13636-7

UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group.BMJ. 1998;317:703–13

Hansson L, Zanchetti A, Carruthers SG, Dahlöf B, Elmfeldt D, Julius S, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group Lancet. 1998;351:1755–62. https://doi.org/10.1016/s0140-6736(98)04311-6.

Article  CAS  Google Scholar 

ACCORD Study Group, Ginsberg HN, Elam MB, Lovato LC, Crouse JR, Leiter LA, et al. Effects of combination lipid therapy in type 2 diabetes mellitus. N Engl J Med. 2010;362:1563–74. https://doi.org/10.1056/NEJMoa1001282

Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HAW, Livingstone SJ, et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet. 2004;364:685–96. https://doi.org/10.1016/S0140-6736(04)16895-5.

Article  CAS  PubMed  Google Scholar 

Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular outcomes in type 1 diabetes: The DCCT/EDIC study 30-year follow-up. Diabetes Care. 2016;39:686–93. https://doi.org/10.2337/dc15-1990

Rodbard HW, Lingvay I, Reed J, de la Rosa R, Rose L, Sugimoto D, et al. Semaglutide added to basal insulin in type 2 diabetes (SUSTAIN 5): a randomized, controlled trial. J Clin Endocrinol Metab [Internet]. 2018 [cited 2021 Dec 20];103:2291–301. https://doi.org/10.1210/jc.2018-00070

Wiviott SD, Raz I, Bonaca MP, Mosenzon O, Kato ET, Cahn A, et al. Dapagliflozin and cardiovascular outcomes in type 2 diabetes. N Engl J Med [Internet]. 2019 [cited 2024 Feb 6];380:347–57. https://doi.org/10.1056/NEJMoa1812389

Gourgari E, Dabelea D, Rother K. Modifiable risk factors for cardiovascular disease in children with type 1 diabetes: can early intervention prevent future cardiovascular events? Curr Diab Rep. 2017;17:134. https://doi.org/10.1007/s11892-017-0968-y.

Article  PubMed  PubMed Central  Google Scholar 

Lim S, Choi SH, Kim KM, Choi SI, Chun EJ, Kim MJ, et al. The association of rate of weight gain during early adulthood with the prevalence of subclinical coronary artery disease in recently diagnosed type 2 diabetes: the MAXWEL-CAD study. Diabetes Care. 2014;37:2491–9. https://doi.org/10.2337/dc13-2365.

Article  CAS  PubMed  Google Scholar 

Ahmadizar F, Souverein P, de Boer A, Maitland-van der Zee AH. Undertreatment of hypertension and hypercholesterolaemia in children and adolescents with type 1 diabetes: long-term follow-up on time trends in the occurrence of cardiovascular disease, risk factors and medications use. Br J Clin Pharmacol. 2018;84:776–85. https://doi.org/10.1111/bcp.13482

Varkevisser RDM, Birnie E, Vollenbrock CE, Mul D, van Dijk PR, van der Klauw MM, et al. Cardiovascular risk management in people with type 1 diabetes: performance using three guidelines. BMJ Open Diabetes Res Care. 2022;10:e002765. https://doi.org/10.1136/bmjdrc-2022-002765.

Article  PubMed  PubMed Central  Google Scholar 

Malik S, Lopez V, Chen R, Wu W, Wong ND. Undertreatment of cardiovascular risk factors among persons with diabetes in the United States. Diabetes Res Clin Pract [Internet]. 2007 [cited 2024 Feb 5];77:126–33. https://doi.org/10.1016/j.diabres.2006.10.016

Malik FS, Sauder KA, Isom S, Reboussin BA, Dabelea D, Lawrence JM, et al. Trends in Glycemic control among youth and young adults with diabetes: the search for diabetes in youth study. Diabetes Care. 2022;45:285–94. https://doi.org/10.2337/dc21-0507.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Weisman A, Rovinski R, Farooqi MA, Lovblom LE, Halpern EM, Boulet G, et al. Commonly measured clinical variables are not associated with burden of complications in long-standing type 1 diabetes: results from the Canadian study of longevity in diabetes. Diabetes Care. 2016;39:e67-68. https://doi.org/10.2337/dc16-0102.

Article  PubMed  Google Scholar 

Liese AD, Reboussin BA, Kahkoska AR, Frongillo EA, Malik FS, Imperatore G, et al. Inequalities in glycemic control in youth with type 1 diabetes over time: intersectionality between socioeconomic position and race and ethnicity. Ann Behav Med. 2022;56:461–71. https://doi.org/10.1093/abm/kaab086.

Article  PubMed  Google Scholar 

Liu JJ, Lim SC, Yeoh LY, Su C, Tai BC, Low S, et al. Ethnic disparities in risk of cardiovascular disease, end-stage renal disease and all-cause mortality: a prospective study among Asian people with type 2 diabetes. Diabet Med. 2016;33:332–9. https://doi.org/10.1111/dme.13020.

Article  CAS  PubMed  Google Scholar 

Shetty NS, Parcha V, Patel N, Yadav I, Basetty C, Li C, et al. AHA Life’s essential 8 and ideal cardiovascular health among young adults. Am J Prev Cardiol [Internet]. 2023 [cited 2024 Jan 26];13:100452. https://doi.org/10.1016/j.ajpc.2022.100452

Ogunwole SM, Golden SH. Social determinants of health and structural inequities—root causes of diabetes disparities. Diabetes Care [Internet]. 2021 [cited 2024 Jan 30];44:11–3. https://doi.org/10.2337/dci20-0060

Powell-Wiley TM, Baumer Y, Baah FO, Baez AS, Farmer N, Mahlobo CT, et al. Social determinants of cardiovascular disease. Circulation Res [Internet]. 2022 [cited 2024 Jan 30];130:782–99. https://doi.org/10.1161/CIRCRESAHA.121.319811

Hill-Briggs F, Adler NE, Berkowitz SA, Chin MH, Gary-Webb TL, Navas-Acien A, et al. Social determinants of health and diabetes: a scientific review. Diabetes Care. 2020;44:258–79. https://doi.org/10.2337/dci20-0053.

Article  PubMed  PubMed Central  Google Scholar 

Acquah I, Hagan K, Javed Z, Taha MB, Valero-Elizondo J, Nwana N, et al. Social determinants of cardiovascular risk, subclinical cardiovascular disease, and cardiovascular events. J Am Heart Assoc. 2023;12:e025581. https://doi.org/10.1161/JAHA.122.025581.

Article  PubMed  PubMed Central  Google Scholar 

Office of Disease Prevention and Health Promotion. Healthy people 2030. U.S. Department of Health and Human Services [cited 2023 Aug 11]. Available from: https://health.gov/healthypeople.

Mayne SL, Loizzo L, Bancks MP, Carnethon MR, Barber S, Gordon-Larsen P, et al. Racial residential segregation, racial discrimination, and diabetes: the coronary artery risk development in young adults study. Health Place. 2020;62:102286. https://doi.org/10.1016/j.healthplace.2020.102286.

Article  PubMed  PubMed Central